These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 21223660

  • 1. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
    Liang S, Zhang SX, Ma QS, Xiao HW, Lü QY, Xie X, Mei SJ, Hu DS, Zhou BP, Li B, Chen JF, Cui FQ, Wang FZ, Liang XF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
    [Abstract] [Full Text] [Related]

  • 2. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS, Liang S, Xiao HW, Zhang SX, Zhuang GH, Zou YH, Tan HZ, Liu JC, Zhang YH, Xu AQ, Zhang L, Feng XX, Hu DS, Wang FZ, Cui FQ, Liang XF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul 10; 38(7):868-876. PubMed ID: 28738457
    [Abstract] [Full Text] [Related]

  • 3. [Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].
    Lü JJ, Li RP, Xu AQ, Zhang L, Song LZ, Yan BY, Ji F, Liu JY, Fang XQ, Wang Z, Zhu DW, Zhang GJ, Feng Y, Xiao ZK, Wang J.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar 10; 34(3):267-72. PubMed ID: 23759235
    [Abstract] [Full Text] [Related]

  • 4. [Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases].
    Ma QS, Zou YH, Zhang SX, Liang S, Xiao HW, Xie X, Mei SJ, Jia WD, Zhang YF, Cui FQ, Wang FZ, Liang XF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug 10; 32(8):764-7. PubMed ID: 22093463
    [Abstract] [Full Text] [Related]

  • 5. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
    Hu M, Chen W.
    Value Health; 2009 Aug 10; 12 Suppl 3():S89-92. PubMed ID: 20586991
    [Abstract] [Full Text] [Related]

  • 6. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
    Lu J, Xu A, Wang J, Zhang L, Song L, Li R, Zhang S, Zhuang G, Lu M.
    BMC Health Serv Res; 2013 Jan 31; 13():37. PubMed ID: 23368750
    [Abstract] [Full Text] [Related]

  • 7. [Economic burden of hepatitis C patients and related influencing factors in Guangdong province].
    Wu QM, Li Y, Fu XB, Yang F, Li J, Huang HZ, Yan J, Lin P.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul 10; 39(7):931-936. PubMed ID: 30060307
    [Abstract] [Full Text] [Related]

  • 8. Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan province of China.
    Che YH, Chongsuvivatwong V, Li L, Sriplung H, Wang YY, You J, Ma SJ, Yan Y, Zhang RY, Shen T, Chen HM, Rao SF, Zhang XL.
    Public Health; 2016 Jan 10; 130():13-20. PubMed ID: 25931438
    [Abstract] [Full Text] [Related]

  • 9. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D.
    Epilepsia; 2009 Oct 10; 50(10):2192-8. PubMed ID: 19583782
    [Abstract] [Full Text] [Related]

  • 10. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.
    Ong SC, Lim SG, Li SC.
    J Viral Hepat; 2009 Jan 10; 16(1):53-63. PubMed ID: 19192158
    [Abstract] [Full Text] [Related]

  • 11. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China.
    Zhang S, Ma Q, Liang S, Xiao H, Zhuang G, Zou Y, Tan H, Liu J, Zhang Y, Zhang L, Feng X, Xue L, Hu D, Cui F, Liang X.
    J Viral Hepat; 2016 Mar 10; 23(3):202-10. PubMed ID: 26663525
    [Abstract] [Full Text] [Related]

  • 12. [Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province].
    Long Y, Lu J, Xu DZ, Hu JX, Jiang JH, Yan YP, Huang JY, Yang J.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul 10; 26(7):494-7. PubMed ID: 16334999
    [Abstract] [Full Text] [Related]

  • 13. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
    Zhang B, Zhang Y, Yang J, Liu X.
    Wei Sheng Yan Jiu; 2007 Nov 10; 36(6):706-10. PubMed ID: 18303632
    [Abstract] [Full Text] [Related]

  • 14. [The analysis of drug cost and direct medical expense in community health management of hypertensive patients].
    Liang XH, Gu DF, Zhang H, Zhu K, Deng Y, Cao J, Zhou ZY, Wang Y, Wan GS, Zhao C, Mu QC, Lu FH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug 10; 45(8):732-6. PubMed ID: 22169696
    [Abstract] [Full Text] [Related]

  • 15. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY, Gong YL, Yu SL, Shao RT, Qin HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun 10; 25(6):474-8. PubMed ID: 15231120
    [Abstract] [Full Text] [Related]

  • 16. Resource use and cost of hepatitis C-related care.
    Nevens F, Colle I, Michielsen P, Robaeys G, Moreno C, Caekelbergh K, Lamotte M, Wyffels V.
    Eur J Gastroenterol Hepatol; 2012 Oct 10; 24(10):1191-8. PubMed ID: 22836284
    [Abstract] [Full Text] [Related]

  • 17. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD.
    Mov Disord; 2006 Sep 10; 21(9):1439-43. PubMed ID: 16773620
    [Abstract] [Full Text] [Related]

  • 18. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.
    Chen X, Wang N, Chen Y, Xiao T, Fu C, Xu B.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep 10; 11():2625-2632. PubMed ID: 27799761
    [Abstract] [Full Text] [Related]

  • 19. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China.
    Xiao J, Lin H, Liu T, Zeng W, Li X, Shao X, Tan Q, Xu Y, Xu X, Zheng H, Ma W.
    Int J Environ Res Public Health; 2015 Nov 02; 12(11):14055-67. PubMed ID: 26540065
    [Abstract] [Full Text] [Related]

  • 20. Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.
    Lee KK, Wu DB, Chow PY, Lee VW, Li H.
    J Gastroenterol Hepatol; 2012 Jul 02; 27(7):1167-74. PubMed ID: 22141402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.